coronavirus
belong
viru
famili
coronavirida
envelop
positivesens
rna
virus
coronaviru
genom
approxim
kb
make
virus
largest
known
rna
virus
coronavirus
infect
varieti
host
speci
includ
human
sever
vertebr
virus
predominantli
caus
respiratori
intestin
tract
infect
induc
wide
rang
clinic
manifest
coronavirus
infect
respiratori
tract
long
recogn
signific
pathogen
domest
companion
anim
caus
mild
sever
respiratori
ill
human
gener
coronavirus
infect
human
classifi
low
pathogen
hcov
includ
hcovhku
highli
pathogen
cov
sever
acut
respiratori
syndrom
cov
sarscov
middl
east
respiratori
syndrom
cov
merscov
low
pathogen
hcov
infect
upper
airway
caus
season
mild
moder
coldlik
respiratori
ill
healthi
individu
contrast
highli
pathogen
hcov
pathogen
hcov
hcov
hereaft
infect
lower
respiratori
tract
caus
sever
pneumonia
sometim
lead
fatal
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
result
high
morbid
mortal
highli
pathogen
hcov
pose
substanti
threat
public
health
epidem
sarscov
infect
approxim
individu
overal
mortal
rate
recent
merscov
cross
speci
infect
individu
result
death
mortal
rate
april
recent
identif
sarslik
coronavirus
bat
merscov
domest
camel
make
like
virus
continu
cross
speci
barrier
caus
addit
outbreak
human
popul
highli
pathogen
hcov
caus
wide
spectrum
clinic
manifest
human
larg
fraction
patient
develop
short
period
moder
clinic
ill
small
substanti
number
patient
experienc
sever
diseas
character
ali
ard
thu
basic
two
group
patient
develop
milder
diseas
resolv
sever
diseas
commonli
fatal
diseas
sever
pathogen
hcov
infect
also
influenc
sever
factor
initi
viral
titer
airway
age
comorbid
condit
infect
individu
younger
individu
year
experi
mildmoder
clinic
ill
elderli
individu
exhibit
wors
outcom
infect
sarscov
merscov
addit
individu
comorbid
condit
diabet
obes
heart
failur
renal
failur
among
other
experi
sever
diseas
particularli
merscov
infect
despit
sever
year
research
specif
factor
caus
unusu
high
morbid
mortal
follow
pathogen
hcov
incomplet
understood
virusinduc
direct
cytopath
effect
viral
evas
host
immun
respons
believ
play
major
role
diseas
sever
howev
studi
human
die
sar
recent
studi
anim
model
suggest
dysregul
immun
respons
occur
result
exuber
inflamm
lethal
diseas
review
discuss
recent
advanc
understand
hcov
pathogenesi
special
emphasi
cytokin
storm
immunopatholog
caus
deleteri
consequ
hcov
infect
sarscov
infect
human
result
acut
respiratori
ill
vari
mild
febril
ill
ali
case
ard
death
clinic
cours
sar
present
three
distinct
phase
initi
phase
character
robust
viru
replic
accompani
fever
cough
symptom
subsid
day
second
clinic
phase
associ
high
fever
hypoxemia
progress
pneumonialik
symptom
despit
progress
declin
viru
titer
toward
end
phase
third
phase
patient
progress
ard
often
result
death
progress
declin
viru
titer
third
phase
thought
result
exuber
host
inflammatori
respons
common
clinic
manifest
mer
includ
flulik
symptom
fever
sore
throat
nonproduct
cough
myalgia
short
breath
dyspnea
rapidli
progress
pneumonia
atyp
present
includ
mild
respiratori
ill
without
fever
chill
wheez
palpit
merscov
human
also
caus
gastrointestin
symptom
abdomin
pain
vomit
diarrhea
major
mer
patient
dyspnea
progress
develop
sever
pneumonia
requir
admiss
intens
care
unit
icu
although
healthi
individu
present
mildmoder
respiratori
ill
immunocompromis
individu
comorbid
condit
experi
sever
respiratori
ill
often
progress
ard
overal
merscov
caus
sever
diseas
primari
index
case
immunocompromis
individu
patient
comorbid
condit
secondari
case
household
contact
healthcar
worker
mostli
asymptomat
show
mild
respiratori
ill
typic
analys
lung
patient
succumb
sar
show
lung
consolid
edema
pleural
effus
focal
hemorrhag
mucopurul
materi
tracheobronchi
tree
diffus
alveolar
damag
dad
promin
histolog
featur
sar
lung
chang
includ
hyalin
membran
format
alveolar
hemorrhag
fibrin
exud
alveolar
space
septal
alveolar
fibrosi
observ
later
stage
stain
viral
antigen
reveal
infect
airway
alveolar
epitheli
cell
vascular
endotheli
cell
macrophag
furthermor
sarscov
viral
particl
viral
genom
also
detect
monocyt
lymphocyt
addit
chang
histolog
examin
lung
patient
die
sar
reveal
extens
cellular
infiltr
interstitium
alveoli
cellular
infiltr
includ
neutrophil
macrophag
macrophag
predomin
cell
type
result
correl
increas
number
neutrophil
monocyt
lower
cell
count
peripher
blood
sampl
patient
fatal
sar
despit
numer
laboratoryconfirm
case
death
due
merscov
infect
sever
countri
one
autopsi
report
mer
human
avail
analysi
lung
tissu
patient
show
pleural
pericardi
abdomin
effus
associ
gener
congest
edema
consolid
lung
similar
sarscov
infect
dad
promin
featur
lung
addit
epitheli
cell
necrosi
slough
bronchiolar
epithelium
alveolar
edema
thicken
alveolar
septa
also
note
immunohistochem
examin
show
merscov
predominantli
infect
airway
alveolar
epitheli
cell
endotheli
cell
macrophag
sever
lung
lesion
correl
extens
infiltr
neutrophil
macrophag
lung
higher
number
cell
peripher
blood
mer
patient
sarscov
product
infect
airway
alveolar
epitheli
cell
infect
hematopoiet
cell
dendrit
cell
dc
monocytemacrophag
pbmcderiv
cell
abort
sarscov
infect
dc
induc
lowlevel
express
antivir
cytokin
moder
upregul
proinflammatori
cytokin
tnf
signific
upregul
inflammatori
chemokin
similarli
sarscovinfect
macrophag
show
delay
elev
level
ifn
proinflammatori
cytokin
addit
sarscovinfect
airway
epitheli
cell
aec
also
produc
larg
amount
delay
excess
product
cytokin
chemokin
thought
induc
dysregul
innat
immun
respons
sarscov
infect
high
serum
level
proinflammatori
cytokin
chemokin
found
sar
patient
sever
diseas
compar
individu
uncompl
sar
convers
sar
patient
sever
diseas
low
level
antiinflammatori
cytokin
addit
proinflammatori
cytokin
chemokin
individu
lethal
sar
show
elev
level
ifn
ifnstimul
gene
isg
compar
healthi
control
individu
mildmoder
diseas
result
first
suggest
possibl
role
ifn
isg
immunopathogenesi
sar
human
thu
appear
studi
dysregul
andor
exagger
cytokin
chemokin
respons
sarscovinfect
aec
dc
macrophag
could
play
import
role
sar
pathogenesi
similar
sar
merscov
infect
human
airway
epitheli
cell
induc
signific
delay
ifn
proinflammatori
cytokin
respons
merscov
replic
activ
human
monocytemacrophag
dc
activ
cell
support
merscov
replic
contrast
sarscov
abort
infect
monocytemacrophag
dc
cell
merscov
infect
cell
monocyt
cell
line
human
peripher
blood
monocytederiv
macrophag
dendrit
cell
induc
delay
elev
level
proinflammatori
cytokin
chemokin
howev
induct
monocytemacrophag
dc
substanti
except
plasmacytoid
dendrit
cell
produc
copiou
amount
ifn
upon
merscov
infect
recent
studi
show
elev
level
serum
proinflammatori
cytokin
chemokin
individu
sever
mer
compar
mild
moder
diseas
high
serum
cytokin
chemokin
level
mer
patient
correl
increas
neutrophil
monocyt
number
lung
peripher
blood
suggest
possibl
role
cell
lung
patholog
sever
inbr
mous
strain
evalu
studi
sarscov
pathogenesi
mice
infect
human
strain
sarscov
sarscovurbani
permiss
viru
replic
develop
mild
lung
patholog
clinic
ill
subsequ
isol
mouseadapt
strain
sarscov
eg
allow
studi
lethal
sar
infect
airway
alveolar
epitheli
cell
epitheli
cell
organ
young
mice
mani
strain
eg
support
replic
lung
resist
develop
signific
clinic
diseas
contrast
young
balbc
mice
infect
develop
lethal
diseas
character
diffus
alveolar
damag
enhanc
monocytemacrophag
neutrophil
accumul
pulmonari
edema
hyalin
membran
format
furthermor
age
mice
strain
develop
lethal
clinic
diseas
succumb
infect
addit
mous
model
sarscov
infect
age
rhesu
macaqu
result
significantli
patholog
young
adult
anim
anim
model
replic
sever
key
featur
sarscov
infect
human
thu
use
investig
sar
pathogenesi
studi
anim
model
particularli
use
elucid
role
cytokin
chemokin
mediat
lung
immunopatholog
follow
hcov
infect
infect
nonhuman
primat
nhp
sarscov
induc
dysregul
immun
respons
result
increas
diseas
sever
age
young
nhp
despit
similar
viral
titer
airway
sinc
enhanc
express
gene
regul
inflamm
viru
titer
correl
diseas
sever
exagger
immun
respons
thought
induc
lethal
diseas
age
nhp
similarli
sarscovinfect
balbc
mice
diseas
sever
age
mice
correl
earli
disproportion
strong
upregul
ardsassoci
inflammatori
gene
signatur
recent
studi
identifi
pathogen
role
ifni
mice
infect
result
show
rapid
sarscov
replic
balbc
mice
induc
delay
respons
accompani
excess
influx
pathogen
inflammatori
monocytemacrophag
imm
accumul
imm
produc
addit
level
monocyt
chemoattract
receptor
stimul
result
accumul
pathogen
imm
turn
enhanc
diseas
sever
infiltr
imm
produc
elev
level
proinflammatori
cytokin
tnf
ino
block
ifn
signal
deplet
imm
neutral
singl
inflammatori
cytokin
tnf
protect
mice
lethal
sarscov
infect
addit
immderiv
proinflammatori
cytokin
sensit
cell
undergo
apoptosi
imped
viru
clearanc
anoth
studi
sarscov
infect
loss
tirdomaincontain
adapterinduc
trif
adapt
molecul
signal
result
distinct
inflammatori
signatur
character
neutrophil
inflammatori
cell
infiltr
dysregul
immun
respons
sarscov
trifdefici
mice
associ
aberr
antivir
ifn
proinflammatori
cytokin
chemokin
tnf
interferonstimul
gene
respons
notabl
viru
titer
significantli
higher
mice
compar
wt
control
although
viral
factor
regul
proinflammatori
respons
neutrophil
monocytemacrophag
remain
identifi
e
protein
sarscov
shown
enhanc
proinflammatori
cytokin
chemokin
inflammasom
activ
via
ion
channel
activ
result
support
notion
higher
viru
titer
dysregul
cytokinechemokin
respons
caus
cytokin
storm
lung
immunopatholog
chang
follow
sarscov
infect
anim
model
employ
studi
mer
includ
rhesu
macaqu
rabbit
marmoset
mice
among
other
merscov
challeng
rhesu
macaqu
develop
mild
moder
diseas
similarli
merscovinfect
rabbit
display
mild
clinic
diseas
mildmoder
perivascular
peribronchiolar
infiltr
lesser
extent
lung
interstiti
inflamm
contrast
marmoset
display
moderatesever
respiratori
diseas
character
bronchointerstiti
pneumonia
alveolar
edema
fibrin
deposit
marmoset
sever
diseas
show
increas
neutrophil
macrophag
infiltr
alveoli
interstiti
septa
although
whether
marmoset
develop
sever
diseas
remain
controversi
although
gross
histolog
lesion
inflammatori
cell
infiltr
merscov
infect
marmoset
resembl
human
diseas
data
avail
describ
cytokin
chemokin
respons
anim
small
laboratori
anim
particularli
rodent
support
merscov
replic
due
inabl
merscovspik
protein
bind
human
ortholog
anim
first
mous
model
studi
mer
gener
intranas
transduct
adenoviru
encod
mice
develop
mild
moder
pneumonia
especi
immunodefici
mice
sever
transgen
mous
model
develop
thereaft
exhibit
variabl
organ
tropism
diseas
sever
depend
promot
drive
express
recent
knockin
mice
express
mous
promot
also
describ
mice
also
develop
moder
clinic
diseas
infect
human
isol
merscov
other
recent
develop
similar
mous
model
show
serial
passag
human
isol
merscov
result
mous
adapt
mice
infect
adapt
viru
caus
lethal
respiratori
ill
use
studi
pathogenesi
overal
delay
aberr
antivir
proinflammatori
cytokin
product
merscovinfect
human
macrophag
dendrit
cell
high
serum
proinflammatori
cytokin
level
patient
sever
diseas
compar
mildmoder
clinic
diseas
suggest
possibl
dysregul
enhanc
cytokin
respons
promot
lung
patholog
follow
merscov
infect
counter
innat
antivir
cytokin
respons
sarscov
merscov
encod
sever
structur
nonstructur
protein
nsp
antagon
antivir
immun
respons
sarscov
encod
dub
subvert
antivir
respons
antagon
ifn
isg
respons
impair
ifn
respons
unknown
mechan
inhibit
ifn
respons
block
phosphoryl
addit
structur
protein
membran
nucleocapsid
n
protein
dampen
ifn
signal
inhibit
unknown
mechan
respect
similarli
merscov
structur
protein
n
accessori
protein
antagon
ifn
respons
note
put
antivir
mechan
demonstr
transient
express
assay
whether
actual
import
context
infecti
viru
remain
determin
structur
nonstructur
protein
antagon
ifn
respons
amplifi
inflammatori
respons
promot
unrestrain
viru
replic
result
increas
viral
pamp
dampen
ifn
signal
stimul
prr
induc
aberr
inflammatori
respons
lack
ifn
signal
also
lead
excess
accumul
low
monocyt
neutrophil
despit
sever
year
research
studi
sar
mer
pathogenesi
specif
host
factor
drive
lung
patholog
follow
hcov
infect
rel
unknown
howev
care
review
literatur
relat
sarscov
merscov
pathogenesi
human
anim
model
highlight
sever
key
factor
may
play
crucial
role
initi
progress
exacerb
inflammatori
respons
rapid
viru
replic
notabl
featur
pathogen
human
coronavirus
sarscov
merscov
virus
replic
high
titer
earli
infect
vitro
vivo
high
replic
could
lead
enhanc
cytopath
effect
product
higher
level
proinflammatori
cytokin
chemokin
infect
epitheli
cell
cytokin
chemokin
turn
orchestr
massiv
infiltr
inflammatori
cell
lung
studi
hcov
infect
human
experiment
anim
demonstr
strong
correl
high
sarscov
merscov
titer
diseas
sever
hcov
infect
airway
andor
alveolar
epitheli
cell
studi
anim
model
especi
mous
model
provid
correl
evid
differenti
diseas
outcom
virus
predominantli
infect
airway
epitheli
cell
versu
airway
alveolar
epitheli
type
type
ii
pneumocyt
cell
strain
permiss
viru
replic
resist
develop
clinic
diseas
viral
antigen
predominantli
locat
airway
epitheli
cell
earli
infect
contrast
highli
suscept
balbc
mice
viru
antigen
detect
lung
airway
alveolar
type
ii
pneumocyt
fig
result
suggest
critic
role
hcovinfect
type
ii
pneumocyt
mediat
lung
patholog
host
suscept
delay
ifn
respons
mention
previou
section
sarscov
merscov
encod
multipl
structur
nonstructur
protein
antagon
ifn
respons
hcov
reach
high
titer
earli
infect
harbor
multipl
protein
inhibit
ifn
respons
suggest
earli
antagon
ifn
respons
might
delay
evad
innat
immun
respons
delay
ifn
signal
orchestr
imm
respons
sensit
cell
apoptosi
result
dysregul
inflammatori
respons
monocytemacrophag
neutrophil
accumul
human
anim
studi
demonstr
accumul
inflammatori
monocytemacrophag
neutrophil
lung
follow
hcov
infect
cell
predomin
sourc
cytokin
chemokin
associ
hcov
lethal
diseas
observ
human
anim
model
epitheli
endotheli
cell
apoptosi
vascular
leakag
one
earliest
consequ
rapid
viru
replic
exuber
proinflammatori
cytokinechemokin
respons
lung
epitheli
endotheli
cell
apoptosi
induc
inflammatori
cell
infiltr
caus
airway
alveolar
epitheli
cell
apoptosi
via
fasfasl
mechan
addit
tnf
releas
imm
also
promot
apoptosi
lung
epitheli
cell
endotheli
cell
unpublish
observ
apoptosi
epitheli
endotheli
cell
compromis
lung
microvascular
alveolar
epitheli
cell
barrier
result
vascular
leakag
alveolar
edema
ultim
result
hypoxia
suboptim
cell
respons
covspecif
cell
crucial
viru
clearanc
limit
damag
host
addit
cell
respons
also
dampen
overact
innat
immun
respons
exuber
inflammatori
respons
caus
pathogen
hcov
diminish
cell
respons
case
sarscov
infect
via
tnfmediat
cell
apoptosi
thu
result
uncontrol
inflammatori
respons
accumul
altern
activ
macrophag
alter
tissu
homeostasi
sar
patient
extend
durat
diseas
dad
accompani
fibrosi
interstiti
alveolar
space
hyperplasia
pneumocyt
similar
histolog
featur
notic
lung
sarscovchalleng
stat
mice
background
lung
mice
reveal
enhanc
perivascular
infiltr
altern
activ
macrophag
neutrophil
fibroblast
accompani
extens
fibrin
deposit
alveolar
collaps
featur
observ
end
stage
ali
ard
human
studi
reveal
abrog
signal
specif
myeloid
cell
result
altern
activ
macrophag
addit
delic
balanc
host
coagul
fibrinolysi
process
regul
tissu
remodel
ali
ard
inflammatori
mediat
play
key
role
pathogenesi
ard
primari
caus
death
patient
infect
sarscov
merscov
sever
proinflammatori
cytokin
includ
gmcsf
reactiv
oxygen
speci
chemokin
contribut
ard
addit
uncontrol
epitheli
cell
prolifer
impair
tissu
remodel
later
stage
induc
ard
lead
pulmonari
fibrosi
death
summari
caus
consequ
cytokin
storm
immunopatholog
hcov
pathogenesi
demonstr
fig
corticosteroid
class
steroid
hormon
exert
antiinflammatori
function
gener
use
suppress
inflammatori
condit
sar
epidem
corticosteroid
mainstay
immunomodulatori
therapi
time
administr
corticosteroid
often
lead
earli
improv
term
reduc
fever
resolut
radiograph
lung
infiltr
better
oxygen
howev
studi
show
benefici
effect
demonstr
advers
outcom
follow
corticosteroid
therapi
sarscov
infect
human
earli
treatment
corticosteroid
sar
patient
enhanc
plasma
viral
load
nonicu
patient
thu
lead
exacerb
diseas
overal
result
show
time
dosag
durat
corticosteroid
therapi
critic
intervent
benefici
hcov
infect
gener
corticosteroid
therapi
recommend
treatment
hcov
respiratori
infect
pegyl
nonpegyl
interferon
investig
therapeut
purpos
hcovinfect
individu
howev
therapeut
use
agent
produc
mix
result
human
anim
model
hcov
infect
earli
administr
ifn
margin
benefici
reduc
viral
load
result
moder
improv
clinic
manifest
contrast
delay
administr
ifn
advantag
compar
placebo
control
similarli
earli
administr
combin
ifn
ribavirin
modestli
amelior
diseas
sever
affect
mortal
restrict
viru
replic
induct
isg
howev
also
exacerb
diseas
enhanc
recruit
function
imm
innat
immun
cell
earli
interferon
respons
protect
sarscovinfect
mice
delay
signal
dysregul
antisarscov
immun
respons
suggest
time
ifn
therapi
critic
determin
diseas
outcom
base
result
administr
receptor
blocker
antagonist
consid
option
prevent
exuber
inflammatori
respons
later
stage
sever
diseas
particularli
sar
contrast
mainli
activ
epitheli
cell
lack
monocytemacrophagemedi
proinflammatori
activ
addit
suppress
neutrophil
recruit
site
inflamm
sinc
sarscov
merscov
predominantli
infect
aec
stimul
antivir
gene
epitheli
cell
without
overstimul
immun
system
use
may
ideal
therapeut
option
oxid
phospholipid
oxpl
shown
promot
ali
increas
lung
macrophag
cytokinechemokin
product
via
signal
influenza
viru
iav
infect
mice
recent
studi
therapeut
administr
antagonist
eritoran
protect
mice
lethal
iav
infect
reduc
level
oxpl
inflammatori
cytokin
chemokin
despit
potent
immunomodulatori
function
eritoran
direct
antivir
activ
suggest
use
amelior
inflammatori
respons
sinc
pathogen
human
coronavirus
caus
acut
lung
injuri
promot
oxpl
product
lung
strategi
suppress
oxpl
either
use
eritoran
similar
compound
could
valu
dampen
hcovinduc
inflamm
mice
infect
iav
receptor
signal
endotheli
cell
shown
orchestr
pathogen
inflammatori
respons
target
agon
restrain
excess
inflammatori
cell
recruit
suppress
proinflammatori
cytokin
chemokin
reduc
iav
induc
morbid
mortal
sarscov
infect
lung
epitheli
cell
endotheli
cell
human
nhp
sarscov
infect
endotheli
cell
may
drive
inflammatori
cytokinechemokin
respons
neutrophil
macrophag
accumul
therefor
agon
could
potenti
therapeut
agent
hcov
patient
dampen
pathogen
cytokin
chemokin
respons
role
excess
immun
respons
cell
demonstr
studi
anim
model
demonstr
pathogen
role
imm
lethal
hcov
infect
mous
model
cardiac
inflamm
system
deliveri
optim
lipid
nanoparticl
contain
short
interf
rna
sirna
effici
degrad
mrna
impair
imm
recruit
site
inflamm
thu
result
improv
diseas
outcom
sinc
hcov
singlestrand
rna
ssrna
virus
stimul
imm
agonist
synthet
ssrna
mimic
induc
strong
inflammatori
respons
possibl
immspecif
signal
promot
excess
inflamm
respons
hcov
infect
thu
antagonisttarget
approach
mitig
inflamm
could
prove
benefici
sever
immunomodulatori
agent
could
amelior
inflammatori
respons
follow
pathogen
hcov
infect
includ
cytokinechemokin
inhibitor
dangerassoci
molecular
pattern
damp
antagonist
studi
anim
model
show
signific
contribut
tnf
acut
lung
injuri
impair
cell
respons
sarscovchalleng
mice
vivo
neutral
tnf
activ
infect
mice
lack
tnfr
provid
protect
sarscovinduc
morbid
mortal
howev
note
tnf
detect
serum
sar
patient
least
later
stage
infect
inflamm
indispens
part
effect
immun
respons
without
success
elimin
infecti
agent
difficult
inflammatori
respons
begin
initi
recognit
pathogen
mediat
immun
cell
recruit
elimin
pathogen
ultim
result
tissu
repair
return
homeostasi
howev
certain
virus
highli
pathogen
cov
iav
ebola
virus
induc
excess
prolong
cytokinechemokin
respons
known
cytokin
storm
result
high
morbid
mortal
due
immunopatholog
although
studi
review
manuscript
provid
evid
cytokin
storm
immunopatholog
occur
pathogen
hcov
infect
yet
suffici
understand
specif
factor
respons
exuber
inflammatori
respons
studi
human
autopsi
anim
model
strongli
suggest
pathogen
role
inflammatori
cytokineschemokin
deriv
imm
neutrophil
therefor
therapeut
intervent
target
proinflammatori
cytokin
chemokin
could
prove
benefici
amelior
undesir
inflammatori
respons
addit
sinc
high
viru
titer
earli
later
stage
infect
strongli
correl
diseas
sever
human
strategi
direct
control
viral
load
well
attenu
inflammatori
respons
might
prove
benefici
therefor
futur
studi
focu
identif
specif
signal
pathway
mediat
inflammatori
respons
hcovinfect
patient
anim
